Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011)
We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004–2005 and 2010–2011, w...
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2014-09, Vol.20 (9), p.O554-O557 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | O557 |
|---|---|
| container_issue | 9 |
| container_start_page | O554 |
| container_title | Clinical microbiology and infection |
| container_volume | 20 |
| creator | Schaumburg, F. Idelevich, E.A. Peters, G. Mellmann, A. von Eiff, C. Becker, K. |
| description | We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004–2005 and 2010–2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim–sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes 003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid. |
| doi_str_mv | 10.1111/1469-0691.12519 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1618154154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14651120</els_id><sourcerecordid>3912923071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5659-98ae21152fa6af70bc03d03a8c4db2d311b95272be3d0234cbfcc1c9c32f2da63</originalsourceid><addsrcrecordid>eNqNkUFrFTEQx4NYbH169iYLXuph20yS3WyO8rBVeKUHK3gL2ewsTdnNPpNsZW9-B79hP4l5vraHgmgYmDD85s_M_Al5A_QE8jsFUauS1gpOgFWgnpGjx8rz_AfVlFLwb4fkZYw3lFLGuXhBDpngkkklj0i6Cui7WDhfGJ_c6GyYWmeGwk--jHO0uE2udYNLy44ZMV0764bB-TJgdDHlruJLMtvrZZjsZO0cCzMHzKkP01icYxiNX4pjRqm4-_mLUYD3r8hBb4aIr-_zinw9-3i1_lRuLs8_rz9sSlvVlSpVY5ABVKw3teklbS3lHeWmsaJrWccBWlUxyVrMZcaFbXtrwSrLWc86U_MVOd7rbsP0fcaY9OjyRsNgPE5z1FBDA5XI8T9oDiUbmdF3T9CbaQ4-L6JBVrxRUuS0Iqd7Kh80xoC93gY3mrBooHrnnd45pXdO6T_e5Y6397pzO2L3yD-YlYFqD_xwAy7_0tPrzcWDsNr3Yb71rcOgo3XoLXYuoE26m9xfh_oNQkS2Zw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753897475</pqid></control><display><type>article</type><title>Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Schaumburg, F. ; Idelevich, E.A. ; Peters, G. ; Mellmann, A. ; von Eiff, C. ; Becker, K.</creator><creatorcontrib>Schaumburg, F. ; Idelevich, E.A. ; Peters, G. ; Mellmann, A. ; von Eiff, C. ; Becker, K. ; Study Group</creatorcontrib><description>We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004–2005 and 2010–2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim–sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes 003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/1469-0691.12519</identifier><identifier>PMID: 24372797</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Genotype ; Germany ; Germany - epidemiology ; Humans ; LA-MRSA ; methicillin-resistant Staphylococcus aureus ; Methicillin-Resistant Staphylococcus aureus - classification ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - genetics ; Methicillin-Resistant Staphylococcus aureus - isolation & purification ; Microbial Sensitivity Tests ; Molecular Typing ; resistance ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus</subject><ispartof>Clinical microbiology and infection, 2014-09, Vol.20 (9), p.O554-O557</ispartof><rights>2013 European Society of Clinical Infectious Diseases</rights><rights>2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases</rights><rights>2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.</rights><rights>Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5659-98ae21152fa6af70bc03d03a8c4db2d311b95272be3d0234cbfcc1c9c32f2da63</citedby><cites>FETCH-LOGICAL-c5659-98ae21152fa6af70bc03d03a8c4db2d311b95272be3d0234cbfcc1c9c32f2da63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1469-0691.12519$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1469-0691.12519$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24372797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schaumburg, F.</creatorcontrib><creatorcontrib>Idelevich, E.A.</creatorcontrib><creatorcontrib>Peters, G.</creatorcontrib><creatorcontrib>Mellmann, A.</creatorcontrib><creatorcontrib>von Eiff, C.</creatorcontrib><creatorcontrib>Becker, K.</creatorcontrib><creatorcontrib>Study Group</creatorcontrib><title>Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011)</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004–2005 and 2010–2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim–sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes 003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Genotype</subject><subject>Germany</subject><subject>Germany - epidemiology</subject><subject>Humans</subject><subject>LA-MRSA</subject><subject>methicillin-resistant Staphylococcus aureus</subject><subject>Methicillin-Resistant Staphylococcus aureus - classification</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - genetics</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation & purification</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular Typing</subject><subject>resistance</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFrFTEQx4NYbH169iYLXuph20yS3WyO8rBVeKUHK3gL2ewsTdnNPpNsZW9-B79hP4l5vraHgmgYmDD85s_M_Al5A_QE8jsFUauS1gpOgFWgnpGjx8rz_AfVlFLwb4fkZYw3lFLGuXhBDpngkkklj0i6Cui7WDhfGJ_c6GyYWmeGwk--jHO0uE2udYNLy44ZMV0764bB-TJgdDHlruJLMtvrZZjsZO0cCzMHzKkP01icYxiNX4pjRqm4-_mLUYD3r8hBb4aIr-_zinw9-3i1_lRuLs8_rz9sSlvVlSpVY5ABVKw3teklbS3lHeWmsaJrWccBWlUxyVrMZcaFbXtrwSrLWc86U_MVOd7rbsP0fcaY9OjyRsNgPE5z1FBDA5XI8T9oDiUbmdF3T9CbaQ4-L6JBVrxRUuS0Iqd7Kh80xoC93gY3mrBooHrnnd45pXdO6T_e5Y6397pzO2L3yD-YlYFqD_xwAy7_0tPrzcWDsNr3Yb71rcOgo3XoLXYuoE26m9xfh_oNQkS2Zw</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Schaumburg, F.</creator><creator>Idelevich, E.A.</creator><creator>Peters, G.</creator><creator>Mellmann, A.</creator><creator>von Eiff, C.</creator><creator>Becker, K.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201409</creationdate><title>Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011)</title><author>Schaumburg, F. ; Idelevich, E.A. ; Peters, G. ; Mellmann, A. ; von Eiff, C. ; Becker, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5659-98ae21152fa6af70bc03d03a8c4db2d311b95272be3d0234cbfcc1c9c32f2da63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Genotype</topic><topic>Germany</topic><topic>Germany - epidemiology</topic><topic>Humans</topic><topic>LA-MRSA</topic><topic>methicillin-resistant Staphylococcus aureus</topic><topic>Methicillin-Resistant Staphylococcus aureus - classification</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - genetics</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation & purification</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular Typing</topic><topic>resistance</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schaumburg, F.</creatorcontrib><creatorcontrib>Idelevich, E.A.</creatorcontrib><creatorcontrib>Peters, G.</creatorcontrib><creatorcontrib>Mellmann, A.</creatorcontrib><creatorcontrib>von Eiff, C.</creatorcontrib><creatorcontrib>Becker, K.</creatorcontrib><creatorcontrib>Study Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schaumburg, F.</au><au>Idelevich, E.A.</au><au>Peters, G.</au><au>Mellmann, A.</au><au>von Eiff, C.</au><au>Becker, K.</au><aucorp>Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011)</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2014-09</date><risdate>2014</risdate><volume>20</volume><issue>9</issue><spage>O554</spage><epage>O557</epage><pages>O554-O557</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004–2005 and 2010–2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim–sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes 003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24372797</pmid><doi>10.1111/1469-0691.12519</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2014-09, Vol.20 (9), p.O554-O557 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1618154154 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Anti-Bacterial Agents - pharmacology Genotype Germany Germany - epidemiology Humans LA-MRSA methicillin-resistant Staphylococcus aureus Methicillin-Resistant Staphylococcus aureus - classification Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-Resistant Staphylococcus aureus - genetics Methicillin-Resistant Staphylococcus aureus - isolation & purification Microbial Sensitivity Tests Molecular Typing resistance Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcus aureus |
| title | Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004–2011) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A44%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20antimicrobial%20non-susceptibility%20in%20methicillin-resistant%20Staphylococcus%20aureus%20from%20Germany%20(2004%E2%80%932011)&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Schaumburg,%20F.&rft.aucorp=Study%20Group&rft.date=2014-09&rft.volume=20&rft.issue=9&rft.spage=O554&rft.epage=O557&rft.pages=O554-O557&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/1469-0691.12519&rft_dat=%3Cproquest_cross%3E3912923071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753897475&rft_id=info:pmid/24372797&rft_els_id=S1198743X14651120&rfr_iscdi=true |